Curator,Gene Name,Disease,Number of base pairs,Number of amino acids,Number of exons,Is alternative splicing predicted?,Alternative splicing comments,Total # of P/LP ClinVar submissions (one star +),Total # of predicted LOF variants (among P/LP 1 star+ submissions),Percentage of pLOF of total P/LP variants,Number of exons with ClinVar pLOF P/LP Variants,Location of pLOF variants (is clustering observed),Notes on clustering,Total number of pLOF variants scored by the GCEP,Number of UNIQUE pLOF variants scored by the GCEP,Number of probands with at least 1 pLOF scored by the GCEP,Experimental evidence,Number of homozygous pLOF variants in gnomAD,GenCC pLOF variant points,GenCC experiemental points,GenCC pLOF spectrum points,GenCC population database points,Total GenCC points,GenCC outcome
Caitlin,AARS2,mitochondrial disease,4798,985,22,No,N/A,57,34,59.6%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.5,0.15,1.35,Established
,AASS,hyperlysinemia,5825,926,24,No,N/A,9,7,77.8%,>3,Clustering is not observed,N/A,5,5,4,0,0,0.8,0,0.3,0.15,1.45,Established
,ABCG5,sitosterolemia,2760,651,13,No,N/A,7,7,100.0%,>3,Clustering is not observed,N/A,7,6,6,0.3,1,1.4,0.3,0.3,0,1.8,Established
,ABCG8,sitosterolemia,7180,673,13,No,N/A,38,35,92.1%,>3,Clustering is not observed,N/A,12,8,9,0.3,3,1.6,0.3,0.5,0,2.4,Established
,ABHD12,PHARC syndrome,1960,398,13,Yes,"Exon 10,5,3,2",27,25,92.6%,>3,Clustering is not observed,N/A,6,6,6,0,1,1.2,0,0.5,0,1.7,Established
,ACAD8,isobutyryl-CoA dehydrogenase deficiency ,2176,415,11,No,N/A,28,15,53.6%,>3,Clustering is not observed,N/A,3,3,3,1,0,0.6,0.3,0.3,0.15,1.35,Established
,ACADVL,very long chain acyl-CoA dehydrogenase deficiency,2184,655,20,Yes,Exon 1,417,265,63.5%,>3,Clustering is not observed,N/A,4,4,3,1,0,0.8,0.3,0.5,0.15,1.75,Established
,ACOX1,peroxisomal acyl-CoA oxidase deficiency,7317,660,14,Yes,Exon 3,60,54,90.0%,>3,Clustering is not observed,N/A,4,4,4,2,0,1,0.3,0.5,0.15,1.95,Established
,ACSF3,combined malonic and methylmalonic acidemia,4095,576,11,Yes,"Exon 1,3,6,10,12",140,136,97.1%,>3,Clustering is not observed,N/A,4,3,4,0,2,0.6,0,0.5,0,1.1,Established
,ADA2,deficiency of adenosine deaminase 2,4355,511,10,No,N/A,64,36,56.3%,>3,Clustering is not observed,N/A,4,3,4,0,1,0.6,0,0.5,0,1.1,Established
,ADAM9,ADAM9-related retinopathy,4112,819,22,Yes,Exon 16,16,15,93.8%,>3,Clustering is not observed,N/A,5,5,5,1,1,1,0.3,0.3,0,1.6,Established
,ADGRG1,bilateral frontoparietal polymicrogyria,4257,687,14,Yes,"Exon 1,4-7,9-10,12,13,15-19,",90,76,84.4%,>3,Clustering is not observed,N/A,18,16,18,0,2,3.2,0,0.5,0,3.7,Established
,ADGRV1,Usher syndrome type 2,19557,6306,90,Yes,"Exons 1-25,75,93-96,100,101",490,469,95.7%,>3,Clustering is not observed,N/A,6,5,4,0.3,1,1,0.3,0.5,0,1.8,Established
,AGA,aspartylglucosaminuria,2037,346,9,No,N/A,79,65,82.3%,>3,Clustering is not observed,N/A,7,7,7,1,0,1.4,0.3,0.5,0.15,2.35,Established
,AGK,mitochondrial disease,3628,422,16,Yes,"Exon 3,5,7,12",32,29,90.6%,>3,Clustering is not observed,N/A,8,8,5,0,1,1.6,0,0.5,0,2.1,Established
,AHI1,Joubert syndrome 3,6063,1196,29,Yes,"Exon 7,18,36",211,180,85.3%,>3,Clustering is not observed,N/A,3,3,3,1,3,0.6,0.3,0.5,0,1.4,Established
,ALDH4A1,hyperprolinemia type 2,3139,563,15,Yes,"Exon 2,9",7,7,100.0%,>3,Clustering is not observed,N/A,4,3,4,0,0,0.6,0,0.3,0.15,1.05,Established
,ALS2,ALS2-related motor neuron disease,6675,1657,34,Yes,"Exons 1-3, 6,7 ",93,84,90.3%,>3,Clustering is not observed,N/A,9,9,9,1,1,1.8,0.3,0.5,0,2.6,Established
,ANGPTL3,familial hypobetalipoproteinemia 2,2926,460,7,Yes,Exon 1,4,4,100.0%,>3,Clustering is not observed,N/A,8,6,6,0.3,1,1.2,0.3,0,0,1.5,Established
,ANTXR2,hyaline fibromatosis syndrome,8419,488,17,Yes,"Exon 1-7, 18,25",32,18,56.3%,>3,Clustering is not observed,N/A,4,3,3,0.1,0,0.6,0.1,0.3,0.15,1.15,Established
,AP4B1,AP-4 deficiency syndrome,3173,730,10,No,N/A,13,13,100.0%,>3,Clustering is not observed,N/A,11,8,9,0,0,1.6,0,0.3,0.15,2.05,Established
,AP4S1,AP-4 deficiency syndrome,4060,144,6,Yes,"Exon 1,9",28,16,57.1%,>3,Clustering is not observed,N/A,9,7,8,0.2,1,1.4,0.2,0.3,0,1.9,Established
,ARFGEF2,"periventricular heterotopia with microcephaly, autosomal recessive",9031,1785,39,No,N/A,19,16,84.2%,>3,Clustering is not observed,N/A,7,7,6,0,0,1.4,0,0.3,0.15,1.85,Established
,ARG1,arginase deficiency,1447,322,8,No,N/A,120,89,74.2%,>3,Clustering is not observed,N/A,4,4,3,0,1,0.8,0,0.5,0,1.3,Established
,ARSA,metachromatic leukodystrophy,4294,509,8,No,N/A,296,135,45.6%,>3,Clustering is not observed,N/A,7,6,7,1,0,1.2,0.3,0.5,0.15,2.15,Established
,ASAH1,ASAH1-related sphingolipidosis,2779,395,14,Yes,"Exon 1,3-6,8,12",96,57,59.4%,>3,Clustering is not observed,N/A,2,2,2,0.1,7,0.2,0.1,0.5,0,1,Established
,ASL,argininosuccinic aciduria,2140,464,17,Yes ,Exon 15,205,108,52.7%,>3,Clustering is not observed,N/A,8,6,5,1,0,1.2,0.3,0.5,0.15,2.15,Established
,ASPA,Canavan disease,5422,313,6,Yes,Exons 1-3,136,84,61.8%,>3,Clustering is not observed,N/A,2,2,2,1,0,0.2,0.3,0.5,0.15,1.35,Established
,ASPM,autosomal recessive primary microcephaly,10863,3477,28,No,N/A,258,253,98.1%,>3,Clustering is not observed,N/A,10,10,9,1,2,2,0.3,0.5,0,2.8,Established
,ATF6,ATF6-related retinopathy,7470,670,16,Yes,Exon 10,32,27,84.4%,>3,Clustering is not observed,N/A,10,7,8,0.2,1,1.4,0.2,0.5,0,2.1,Established
,ATP13A2,Kufor-Rakeb syndrome,3996,1180,29,Yes,Exon 1,61,58,95.1%,>3,Clustering is not observed,N/A,6,6,5,0.2,0,1.2,0.2,0.5,0.15,2.05,Established
,ATP6V0A2,autosomal recessive cutis laxa type 2A,6507,856,20,Yes,"Exons 10,11",31,29,93.5%,>3,Clustering is not observed,N/A,7,7,6,0,1,1.4,0,0.5,0,1.9,Established
,ATP7B,Wilson disease,6598,1465,21,Yes,"Exon 1, 26",686,471,68.7%,>3,Clustering is not observed,N/A,4,3,4,0.3,1,0.6,0.3,0.5,0,1.4,Established
,B9D1,ciliopathy,913,204,7,Yes,Exon 1-6,9,5,55.6%,<3,Clustering observed,ClinVar shows 5 variants across two exons; gnomAD shows 3 variants across two exons,2,2,2,2,2,0.4,0.3,0.3,0,1,Established
,BBS12,BBS12-related ciliopathy,3238,710,2,No,N/A,137,128,93.4%,<3,"Cannot determine, only 1 exon",ClinVar and gnomAD show that all the variants are in one exon,4,4,3,0,0,0.8,0,0.5,0.15,1.45,Established
,BCKDHB,maple syrup urine disease type 1B,3668,392,10,Yes,"Exons 2,5,8,12",185,132,71.4%,>3,Clustering is not observed,N/A,6,5,5,0,0,1,0,0.5,0.15,1.65,Established
,BCKDK,branched-chain keto acid dehydrogenase kinase deficiency,2036,412,12,Yes,"Exons 1,2,4",7,6,85.7%,>3,Clustering is not observed,N/A,2,2,2,1,0,0.4,0.3,0.3,0.15,1.15,Established
,BCS1L,Bjornstad syndrome,1427,419,8,Yes,Exon 1,107,81,75.7%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.5,0.15,1.25,Established
,BRAT1,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,2779,821,14,Yes,Exon 12,81,70,86.4%,>3,Clustering is not observed,N/A,9,4,8,0,0,0.8,0,0.5,0.15,1.45,Established
,BRAT1,neonatal-onset encephalopathy with rigidity and seizures,2779,821,14,Yes,Exon 12,81,70,86.4%,>3,Clustering is not observed,N/A,8,7,7,0,0,1.4,0,0.5,0.15,2.05,Established
,BSND,Bartter disease type 4A,9761,320,4,No,N/A,27,20,74.1%,3,Clustering is not observed,N/A,2,2,2,0.2,0,0.4,0.2,0.5,0.15,1.25,Established
,BTD,biotinidase deficiency,9964,523,4,Yes,"Exon 1,5-7",188,102,54.3%,>3,Clustering is not observed,N/A,5,5,5,1,1,1,0.3,0.5,0,1.8,Established
,CA5A,hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,1113,305,7,No,N/A,5,4,80.0%,3,Clustering is not observed,N/A,8,4,8,1,2,0.8,0.3,0.3,0,1.4,Established
,CAPN3,autosomal recessive limb-girdle muscular dystrophy,3315,821,24,Yes ,Exon 2,370,271,73.2%,>3,Clustering is not observed,N/A,6,3,6,1,0,0.6,0.3,0.5,0.15,1.55,Established
,CASQ2,catecholaminergic polymorphic ventricular tachycardia,2593,399,11,Yes,Exon 6,61,51,83.6%,>3,Clustering is not observed,N/A,9,8,9,0.3,0,1.6,0.3,0.5,0.15,2.55,Established
,CBS,classic homocystinuria,2495,551,17,Yes,"Exon 1,3-7,17-21,23",245,139,56.7%,>3,Clustering is not observed,N/A,4,4,4,1,3,0.8,0.3,0.5,0,1.6,Established
,CCDC39,primary ciliary dyskinesia 14,3848,941,20,Yes,Exon 38,121,113,93.4%,>3,Clustering is not observed,N/A,10,10,7,0.2,0,2,0.2,0.5,0.15,2.85,Established
,CD19,"immunodeficiency, common variable, 3",1918,556,15,No,N/A,8,7,87.5%,>3,Clustering is not observed,N/A,5,5,5,2,0,1,0.3,0.3,0.15,1.75,Established
,CD3E,immunodeficiency 18,1361,207,9,No,N/A,15,15,100.0%,>3,Clustering is not observed,N/A,9,9,8,0.2,0,1.8,0.2,0.3,0.15,2.45,Established
,CDK5RAP2,autosomal recessive primary microcephaly,6232,1893,38,Yes,"Exon 8,10",44,42,95.5%,>3,Clustering is not observed,N/A,8,8,5,1,0,1.6,0.3,0.5,0.15,2.55,Established
,CDT1,Meier-Gorlin syndrome 4,2664,546,10,No,N/A,15,11,73.3%,>3,Clustering is not observed,N/A,4,3,4,0.1,0,0.6,0.1,0.3,0.15,1.15,Established
,CENPJ,microcephaly 6 with or without short stature,5082,1338,17,No,N/A,44,43,97.7%,>3,Clustering is not observed,N/A,10,10,8,1,2,2,0.3,0.5,0,2.8,Established
,CEP164,ciliopathy,5629,1460,33,Yes,"Exons 1,7,11",93,91,97.8%,>3,Clustering is not observed,N/A,7,6,5,2,0,1.2,0.3,0.5,0.15,2.15,Established
,CFL2,nemaline myopathy 7,4306,166,4,Yes,Exon 2,7,4,57.1%,<3,"Cannot determine, only 1 exon",3 variants in 1 exon,4,4,4,1,0,0.8,0.3,0.3,0.15,1.55,Established
,CLDN14,nonsyndromic genetic hearing loss,1784,239,2,Yes,"Exon 1,7",10,6,60.0%,<3,"Cannot determine, only 1 exon",all variants in 1 exon,3,3,3,1,0,0.6,0.3,0.3,0.15,1.35,Established
,CNNM4,Jalili syndrome,4873,775,7,No,N/A,33,21,63.6%,>3,Clustering is not observed,N/A,5,4,5,0.2,0,1,0.2,0.5,0.15,1.65,Established
,CNTN2,Complex neurodevelopmental disorder,7916,1040,23,Yes,"Exons 1,15,18",22,22,100.0%,>3,Clustering is not observed,N/A,5,5,5,1,2,1,0.3,0.5,0,1.8,Established
,COL7A1,recessive dystrophic epidermolysis bullosa,9231,2944,119,Yes,Exon 1,806,551,68.4%,>3,Clustering is not observed,N/A,4,4,4,0,1,0.8,0,0.5,0,1.3,Established
,CORO1A,severe combined immunodeficiency due to CORO1A deficiency,1623,461,11,Yes,Exons 1-6,8,7,87.5%,>3,Clustering is not observed,N/A,4,3,3,3,1,0.6,0.3,0.3,0,1.2,Established
,CPS1,carbamoyl phosphate synthetase I deficiency disease,5760,1500,38,Yes,"Exon 14,25",306,259,84.6%,>3,Clustering is not observed,N/A,14,12,12,2,0,2.4,0.3,0.5,0.15,3.35,Established
,CRADD,syndromic intellectual disability,1189,199,3,Yes,"Exon 2,4,6,9-12",5,3,60.0%,>3,Clustering is not observed,"There are only two variants, but they are in different exons. ",2,2,2,1,0,0.4,0.3,0.3,0.15,1.15,Established
,CSPP1,Joubert syndrome 21,4859,1226,31,Yes,"Exons 3,5,7,14,18,23",85,84,98.8%,>3,Clustering is not observed,N/A,43,19,30,0,2,3.8,0,0.5,0,4.3,Established
,CTH,cystathioninuria,2090,405,12,No,N/A,2,2,100.0%,<3,Clustering is not observed,"There are only two variants, but they are in different exons. ",2,2,2,1,0,0.4,0.3,0.3,0.15,1.15,Established
,CTNS,cystinosis,4139,367,12,No,N/A,85,60,70.6%,>3,Clustering is not observed,N/A,3,3,2,2,0,0.6,0.3,0.5,0.15,1.55,Established
,DARS2,mitochondrial disease,3336,645,17,Yes,"Exon 1,15",54,36,66.7%,>3,Clustering is not observed,N/A,7,7,7,0,1,1.4,0,0.5,0,1.9,Established
,DBT,maple syrup urine disease,10799,482,11,No,N/A,134,109,81.3%,>3,Clustering is not observed,N/A,7,7,6,1,0,1.4,0.3,0.5,0.15,2.35,Established
,DCLRE1C,severe combined immunodeficiency due to DCLRE1C deficiency,5960,692,14,No,N/A,134,117,87.3%,>3,Clustering is not observed,N/A,6,4,5,0.2,0,0.8,0.2,0.5,0.15,1.65,Established
,DDB2,xeroderma pigmentosum group E,1815,427,10,Yes,Exon 1,9,8,88.9%,>3,Clustering is not observed,N/A,3,3,3,2,0,0.6,0.3,0.3,0.15,1.35,Established
,DDHD1,hereditary spastic paraplegia,12941,900,13,Yes,"Exon 2,14,19",17,17,100.0%,>3,Clustering is not observed,N/A,2,2,2,1,0,0.4,0.3,0.3,0.15,1.15,Established
,DHCR7,Smith-Lemli-Opitz syndrome,2627,475,9,Yes,"Exon 1,11",211,105,49.8%,>3,Clustering is not observed,N/A,6,5,5,2,1,1,0.3,0.5,0,1.8,Established
,DNAH11,primary ciliary dyskinesia 7,14343,4516,82,Yes,"Exons 24,33,34,41,72",412,376,91.3%,>3,Clustering is not observed,N/A,7,7,6,0.2,2,1.4,0.2,0.5,0,2.1,Established
,DNAI1,primary ciliary dyskinesia 1,2529,699,20,Yes,"Exon 1,7",124,114,91.9%,>3,Clustering is not observed,N/A,9,7,8,0.3,0,1.4,0.3,0.5,0.15,2.35,Established
,DOCK8,combined immunodeficiency due to DOCK8 deficiency,7448,2099,48,Yes,"Exons 1,6,29,39",77,71,92.2%,>3,Clustering is not observed,N/A,14,14,11,0.2,0,2.8,0.2,0.5,0.15,3.65,Established
,EARS2,Leigh syndrome,5196,523,9,Yes,"Exon 2,3,5-7",25,13,52.0%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.3,0.15,1.05,Established
,EPM2A,Lafora disease,3129,331,4,Yes,"Exon 3,5-7,9,11,12,14-16",22,15,68.2%,>3,Clustering is not observed,N/A,11,11,10,1,0,2.2,0.3,0.3,0.15,2.95,Established
,EPS8,Autosomal recessive nonsyndromic hearing loss 102,3901,822,21,Yes,"Exons 1,4-8,16,18",7,7,100.0%,>3,Clustering is not observed,N/A,2,2,2,1,0,0.4,0.3,0.3,0.15,1.15,Established
,ERCC2,xeroderma pigmentosum group D,4108,760,23,Yes,Exon 27,169,145,85.8%,>3,Clustering is not observed,N/A,3,3,3,0,1,0.6,0,0.5,0,1.1,Established
,ERCC3,xeroderma pigmentosum group B,2718,782,15,No,N/A,41,40,97.6%,>3,Clustering is not observed,N/A,8,6,5,0,2,1.2,0,0.5,0,1.7,Established
,ERCC4,xeroderma pigmentosum group F,6764,916,11,Yes,Exon 4,40,34,85.0%,>3,Clustering is not observed,N/A,3,3,3,1,0,0.6,0.3,0.5,0.15,1.55,Established
,ERCC5,xeroderma pigmentosum group G,3888,1186,15,Yes,Exon 3,36,31,86.1%,>3,Clustering is not observed,N/A,8,7,6,1,1,1.4,0.3,0.5,0,2.2,Established
,ERCC8,Cockayne syndrome type 1,9414,396,12,Yes,Exon 14,84,73,86.9%,>3,Clustering is not observed,N/A,8,8,5,0,0,1.6,0,0.5,0.15,2.25,Established
,ESPN,nonsyndromic genetic hearing loss,3543,854,13,Yes,"Exon 3,4,11,20",14,11,78.6%,>3,Clustering is not observed,N/A,6,6,3,0.3,2,1.2,0.3,0.5,0,2,Established
,ETFB,multiple acyl-CoA dehydrogenase deficiency,872,255,6,No,N/A,28,22,78.6%,>3,Clustering is not observed,N/A,6,6,5,0,1,1.2,0,0.5,0,1.7,Established
,ETFDH,multiple acyl-CoA dehydrogenase deficiency,3111,617,13,Yes,Exon 4,242,144,59.5%,>3,Clustering is not observed,N/A,6,6,6,0,1,1.2,0,0.5,0,1.7,Established
,EYS,EYS-related retinopathy,10590,3144,43,Yes,"Exon 1,5,26,38,40,45,49",682,652,95.6%,>3,Clustering is not observed,N/A,8,8,7,0.3,2,1.6,0.3,0.5,0,2.4,Established
,F13A1,"factor XIII, A subunit, deficiency of",3828,732,15,Yes,"Exon 1,10",20,14,70.0%,>3,Clustering is not observed,N/A,6,6,6,2,1,1.2,0.3,0.3,0,1.8,Established
,F5,congenital factor V deficiency,9132,2224,25,No,N/A,63,55,87.3%,>3,Clustering is not observed,N/A,6,6,6,1,0,1.2,0.3,0.5,0.15,2.15,Established
,F7,factor VII deficiency,3063,444,8,Yes,Exon 6,57,17,29.8%,>3,Clustering is not observed,N/A,5,4,5,1,1,0.8,0.3,0,0,1.1,Established
,F10,congenital factor X deficiency,1536,488,8,Yes,Exon 3,21,8,38.1%,>3,Clustering is not observed,N/A,7,6,5,0.2,0,1.2,0.2,0.3,0.15,1.85,Established
,FANCA,Fanconi anemia complementation group A,5452,1455,43,No,N/A,550,507,92.2%,>3,Clustering is not observed,N/A,8,7,7,0.3,1,1.4,0.3,0.5,0,2.2,Established
,FANCC,Fanconi anemia complementation group C,4592,558,15,Yes,"Exon 4,5",102,98,96.1%,>3,Clustering is not observed,N/A,9,7,5,2,0,1.4,0.3,0.5,0.15,2.35,Established
,FANCE,Fanconi anemia complementation group E,2576,536,10,No,N/A,49,47,95.9%,>3,Clustering is not observed,N/A,4,4,4,0,0,0.8,0,0.5,0.15,1.45,Established
,FANCF,Fanconi anemia complementation group F,3291,374,1,No,N/A,36,32,88.9%,<3,"Cannot determine, only 1 exon",All variants in 1 exon,8,5,6,1,0,1,0.3,0,0.15,1.45,Established
,FANCG,Fanconi anemia complementation group G,2556,622,14,No,N/A,157,149,94.9%,>3,Clustering is not observed,N/A,5,5,5,2,0,1,0.3,0.5,0.15,1.95,Established
,FANCL,Fanconi anemia complementation group L,1658,375,14,No,N/A,93,85,91.4%,>3,Clustering is not observed,N/A,7,7,6,0,1,1.4,0,0.5,0,1.9,Established
,FGD4,Charcot-Marie-Tooth disease,8465,903,17,Yes,"Exons 1,4,7",39,37,94.9%,>3,Clustering is not observed,N/A,5,5,5,1,1,1,0.3,0.5,0,1.8,Established
,FGF3,"deafness with labyrinthine aplasia, microtia, and microdontia",1540,239,3,No,N/A,7,5,71.4%,<3,Clustering is not observed,N/A,5,3,5,2,0,0.6,0.3,0,0.15,1.05,Established
,FOLR1,neurodegenerative syndrome due to cerebral folate transport deficiency,930,257,4,No,N/A,21,17,81.0%,>3,Clustering is not observed,N/A,6,5,5,0.2,1,1,0.2,0.3,0,1.5,Established
,FOXRED1,Leigh syndrome,1951,486,11,No,N/A,47,41,87.2%,>3,Clustering is not observed,N/A,1,1,1,0.3,0,0.2,0.3,0.5,0.15,1.15,Established
,FXN,Friedreich ataxia,6978,210,5,Yes,Exon 2,9,6,66.7%,>3,Clustering is not observed,N/A,13,5,9,1,0,1,0.3,0.3,0.15,1.75,Established
,GAA,glycogen storage disease II,3751,952,20,No,N/A,621,388,62.5%,>3,Clustering is not observed,N/A,5,5,4,1,0,1,0.3,0.5,0.15,1.95,Established
,GALC,Krabbe disease,3794,685,17,Yes,"Exons 4,17,26",296,201,67.9%,>3,Clustering is not observed,N/A,7,7,4,1,0,1.4,0.3,0.5,0.15,2.35,Established
,GALK1,galactokinase deficiency,1397,392,8,Yes,Exon 3,83,74,89.2%,>3,Clustering is not observed,N/A,4,4,4,1,0,0.8,0.3,0.5,0.15,1.75,Established
,GALNS,mucopolysaccharidosis type 4A,2344,522,14,Yes,Exon 12,234,133,56.8%,>3,Clustering is not observed,N/A,2,2,2,0.2,1,0.4,0.2,0.5,0,1.1,Established
,GALNT3,"tumoral calcinosis, hyperphosphatemic, familial, 1",3436,633,11,Yes,"Exon 2,3,7",48,40,83.3%,>3,Clustering is not observed,N/A,6,5,5,2,0,1,0.3,0.5,0.15,1.95,Established
,GAN,giant axonal neuropathy 1,15159,597,11,Yes,Exon 10,41,36,87.8%,>3,Clustering is not observed,N/A,8,8,8,0,0,1.6,0,0.5,0.15,2.25,Established
,GBE1,glycogen storage disease due to glycogen branching enzyme deficiency,2941,702,16,Yes,"Exon 2,5",155,123,79.4%,>3,Clustering is not observed,N/A,12,11,11,3,0,2.2,0.3,0.5,0.15,3.15,Established
,GCDH,glutaryl-CoA dehydrogenase deficiency,1852,438,12,Yes,"Exons 5,12,14,16",227,85,37.4%,>3,Clustering is not observed,N/A,5,5,5,1,0,1,0.3,0.5,0.15,1.95,Established
,GIPC3,nonsyndromic genetic hearing loss,4410,312,6,No,N/A,6,4,66.7%,3,Clustering is not observed,N/A,2,2,2,1,1,0.4,0.3,0.3,0,1,Established
,GLB1,GM1 gangliosidosis,2523,677,16,Yes,"Exon 2,3,16",235,123,52.3%,>3,Clustering is not observed,N/A,4,4,4,0,0,0.8,0,0.5,0.15,1.45,Established
,GLDC,glycine encephalopathy,3843,1020,25,Yes,"Exon 3,4,8,19,21",361,243,67.3%,>3,Clustering is not observed,N/A,8,8,8,1,1,1.6,0.3,0.5,0,2.4,Established
,GMPPA,"alacrima, achalasia, and intellectual disability syndrome",1522,420,13,No,N/A,9,9,100.0%,>3,Clustering is not observed,N/A,6,6,6,1,0,1.2,0.3,0.3,0.15,1.95,Established
,GNS,mucopolysaccharidosis type 3D,5081,552,14,Yes,Exon 2,63,61,96.8%,>3,Clustering is not observed,N/A,8,8,8,1,0,1.6,0.3,0.5,0.15,2.55,Established
,GP6,platelet-type bleeding disorder 11,2264,339,8,No,N/A,10,10,100.0%,>3,Clustering is not observed,N/A,6,3,6,1,4,0.6,0.3,0.3,0,1.2,Established
,GRIK2,Complex neurodevelopmental disorder,4722,908,17,Yes,Exon 7,7,4,57.1%,>3,Clustering is not observed,N/A,2,2,2,1,1,0.4,0.3,0.3,0,1,Established
,GRM6,GRM6-related retinopathy,6025,877,11,Yes,"Exon 1,2",21,17,81.0%,3,Clustering is not observed,N/A,4,4,4,1,1,0.8,0.3,0.3,0,1.4,Established
,GRXCR1,nonsyndromic genetic hearing loss,1545,290,4,Yes,Exon 1,9,6,66.7%,>3,Clustering is not observed,N/A,6,6,6,0,0,1.2,0,0.3,0.15,1.45,Established
,GUSB,mucopolysaccharidosis type 7,2199,651,12,Yes,Exon 2,62,44,71.0%,>3,Clustering is not observed,N/A,7,7,4,1,0,1.4,0.3,0.5,0.15,2.35,Established
,HEXB,Sandhoff disease,1812,556,14,Yes,"Exon 1,16,17",163,135,82.8%,>3,Clustering is not observed,N/A,6,5,5,3,0,1,0.3,0.5,0.15,1.95,Established
,HGSNAT,mucopolysaccharidosis type 3C,5227,635,18,Yes,"Exon 6,14",124,109,87.9%,>3,Clustering is not observed,N/A,8,8,5,1,0,1.6,0.3,0.5,0.15,2.55,Established
,HLCS,holocarboxylase synthetase deficiency,8273,873,11,Yes,Exons 2-4,158,143,90.5%,>3,Clustering is not observed,N/A,4,3,4,0,0,0.6,0,0.5,0.15,1.25,Established
,HPS1,Hermansky-Pudlak syndrome 1,3703,700,20,No,N/A,151,140,92.7%,>3,Clustering is not observed,N/A,12,8,10,1,0,1.6,0.3,0.5,0.15,2.7,Established
,HPS3,Hermansky-Pudlak syndrome 3,4611,1004,17,Yes,Exon 20,182,178,97.8%,>3,Clustering is not observed,N/A,8,8,7,0,0,1.6,0,0.5,0.15,2.25,Established
,HSD17B4,Perrault syndrome,2628,736,24,Yes,"Exon 8,11,16,22",194,164,84.5%,>3,Clustering is not observed,N/A,5,5,5,0,0,1,0,0.5,0.15,1.65,Established
,HSD3B7,congenital bile acid synthesis defect 1,2171,369,7,No,N/A,20,19,95.0%,>3,Clustering is not observed,N/A,3,3,3,1,0,0.6,0.3,0.3,0.15,1.35,Established
,HSPG2,Silverman-Handmaker type dyssegmental dysplasia,14341,4391,97,No,N/A,69,60,87.0%,>3,Clustering is not observed,N/A,5,5,5,2,0,1,0.3,0.5,0.15,1.95,Established
,IDUA,mucopolysaccharidosis type 1,2174,653,14,No,N/A,250,175,70.0%,>3,Clustering is not observed,N/A,10,9,9,0,1,1.8,0,0.5,0,2.3,Established
,IFT140,IFT140-related recessive ciliopathy,5232,1462,31,Yes,"Exon 3,21",66,60,90.9%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,INPP5E,Joubert syndrome 1,3417,644,10,No,N/A,64,31,48.4%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.5,0.15,1.25,Established
,ITGA3,"epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome",4889,1051,26,Yes,"Exon 1,23",12,9,75.0%,>3,Clustering is not observed,N/A,5,5,5,4,0,1,0.3,0.3,0.15,1.95,Established
,ITK,lymphoproliferative syndrome 1,4508,620,17,Yes,Exon 2,11,11,100.0%,>3,Clustering is not observed,N/A,6,4,5,1,0,0.8,0.3,0.3,0.15,1.55,Established
,KCNV2,inherited retinal dystrophy,2178,545,2,No,N/A,59,48,81.4%,<3,"Cannot determine, only 1 exon",All variants in 1 exon,8,7,8,0.3,1,1.4,0.3,0,0,1.7,Established
,KCTD7,progressive myoclonus epilepsy,4869,289,4,No,N/A,25,15,60.0%,>3,Clustering is not observed,N/A,6,5,6,1,1,1,0.3,0.3,0,1.6,Established
,KIFBP,Goldberg-Shprintzen syndrome,2462,621,7,Yes,"Exons 2-5, 9,13,14,16",6,6,100.0%,>3,Clustering is not observed,N/A,9,9,9,0,0,1.8,0,0.3,0.15,2.25,Established
,LCA5,LCA5-related retinopathy,4564,697,8,No,N/A,128,123,96.1%,>3,Clustering is not observed,N/A,5,5,5,1,1,1,0.3,0.5,0,1.8,Established
,LINS1,Complex neurodevelopmental disorder,4755,757,7,Yes,"Exon 1,2,4",22,22,100.0%,3,Clustering is not observed,N/A,7,7,6,0,1,1.4,0,0.5,0,1.9,Established
,LIPA,obsolete lysosomal acid lipase deficiency,2496,399,10,No,N/A,119,74,62.2%,>3,Clustering is not observed,N/A,5,5,5,1,1,1,0.3,0.5,0,1.8,Established
,LMAN1,"factor V and factor VIII, combined deficiency of, type 1",4824,510,13,No,N/A,4,4,100.0%,>3,Clustering is not observed,N/A,15,14,14,0.3,0,2.8,0.3,0.3,0.15,3.55,Established
,LOXHD1,nonsyndromic genetic hearing loss,7208,2273,41,Yes,"Exon 1-10,32",326,318,97.5%,>3,Clustering is not observed,N/A,9,8,9,0,1,1.6,0,0.5,0,2.1,Established
,LPIN2,Majeed syndrome,6052,896,20,Yes,"Exon 4,5",35,33,94.3%,>3,Clustering is not observed,N/A,4,4,4,0,1,0.8,0,0.5,0,1.3,Established
,LRBA,combined immunodeficiency due to LRBA deficiency,10148,2852,57,Yes,"Exon 39,41,43",114,113,99.1%,>3,Clustering is not observed,N/A,5,5,4,0.1,0,1,0.1,0.5,0.15,1.75,Established
,LYST,Chediak-Higashi syndrome,13466,3801,53,Yes,"Exons 35,46",189,185,97.9%, >3,Clustering is not observed,N/A,8,7,7,1,0,1.4,0.3,0.5,0.15,2.35,Established
,MAN2B1,alpha-mannosidosis,3185,1011,24,Yes,"Exons 13,14,27",275,255,92.7%,>3,Clustering is not observed,N/A,8,8,6,1,1,1.6,0.3,0.5,0,2.4,Established
,MCCC1,3-methylcrotonyl-CoA carboxylase deficiency,2454,725,19,Yes,"Exons 1,3,6",166,144,86.7%,>3,Clustering is not observed,N/A,6,6,5,0,0,1.2,0,0.5,0.15,1.85,Established
,MCFD2,"factor 5 and Factor VIII, combined deficiency of, 2",4120,146,4,Yes,"Exon 4,5",7,5,71.4%,<3,Clustering is not observed,"Two variants, in two different exons",5,5,5,0.3,0,1,0.3,0,0.15,1.45,Established
,MCPH1,microcephaly with intellectual disability,8008,835,14,Yes,"Exon 9,10,13",60,54,90.0%,>3,Clustering is not observed,N/A,5,5,5,0,5,1,0,0.5,0,1.5,Established
,MFSD8,neuronal ceroid lipofuscinosis,4422,518,12,Yes,Exon 1,122,109,89.3%,>3,Clustering is not observed,N/A,7,7,6,1,0,1.4,0.3,0.5,0.15,2.35,Established
,MMAB,"methylmalonic aciduria, cblB type",4090,250,9,Yes,"Exon 1,2,4,6",61,45,73.8%,>3,Clustering is not observed,N/A,4,4,4,0,0,0.8,0,0.5,0.15,1.45,Established
,MMADHC,inborn disorder of cobalamin metabolism and transport,1392,296,8,Yes,Exon 6,58,57,98.3%,>3,Clustering is not observed,N/A,9,9,8,0,0,1.8,0,0.5,0.15,2.45,Established
,MMUT,methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency,3811,750,13,No,N/A,342,186,54.4%,>3,Clustering is not observed,N/A,9,9,8,0,0,0.4,0,0.5,0.15,1.05,Established
,MOCS2,sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,4166,188,7,No,N/A,33,32,97.0%,>3,Clustering is not observed,N/A,5,5,5,1,0,0.8,0.3,0.5,0.15,1.75,Established
,MSH3,familial adenomatous polyposis 4,4443,1137,24,Yes,Exon 1,429,424,98.8%,>3,Clustering is not observed,N/A,5,5,3,1,2,1,0.3,0.5,0,1.8,Established
,MSRB3,nonsyndromic genetic hearing loss,4377,185,7,Yes,"Exons 2,5,8",6,4,66.7%,>3,Clustering is not observed,N/A,2,2,2,1,0,0.4,0.3,0.3,0.15,1.15,Established
,MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,7018,656,12,Yes,Exon 1,154,109,70.8%,>3,Clustering is not observed,N/A,6,5,6,1,0,1,0.3,0.5,0.15,1.95,Established
,MTMR2,demyelinating hereditary motor and sensory neuropathy,4495,643,15,Yes,"Exon 6, 10",39,36,92.3%,>3,Clustering is not observed,N/A,8,7,7,1,6,1.4,0.3,0.5,0,2.2,Established
,MTO1,mitochondrial disease,10698,692,12,Yes,Exon 13,47,39,83.0%,>3,Clustering is not observed,N/A,4,4,4,0,2,0.8,0,0.5,0,1.3,Established
,MUTYH,familial adenomatous polyposis 2,1708,521,16,No,N/A,305,266,87.2%,>3,Clustering is not observed,N/A,4,2,4,1,1,0.4,0.3,0.5,0,1.2,Established
,MYO3A,nonsyndromic genetic hearing loss,5624,1616,35,Yes,Exon 1,42,40,95.2%,>3,Clustering is not observed,N/A,5,5,4,1,3,1,0.3,0.5,0,1.8,Established
,MYO5A,Griscelli syndrome type 1,12130,1880,42,Yes,"Exon 1,36",3,3,100.0%,>3,Clustering is not observed,N/A,6,6,6,0.3,2,1.2,0.3,0.3,0,1.8,Established
,NBN,Nijmegen breakage syndrome,4622,754,16,Yes,"Exon 1,2,4",473,465,98.3%,>3,Clustering is not observed,N/A,9,9,8,1,0,1.8,0.3,0.5,0.15,2.75,Established
,NDUFS6,mitochondrial disease,518,124,4,Yes,Exon 2,32,28,87.5%,>3,Clustering is not observed,N/A,2,2,2,0,0,0.4,0,0.5,0.15,1.05,Established
,NPC1,"Niemann-Pick disease, type C1",4760,1278,25,Yes,"Exons 28,30",525,343,65.3%,>3,Clustering is not observed,N/A,5,5,5,0,0,1,0,0.5,0.15,1.65,Established
,NPHP1,nephronophthisis 1,2522,677,20,Yes,"Exon 2,5",106,102,96.2%,>3,Clustering is not observed,N/A,6,5,4,0.1,5,1,0.1,0.5,0,1.6,Established
,NPHP4,nephronophthisis 4,4955,1426,30,Yes,"Exon 18,24,25",106,104,98.1%,>3,Clustering is not observed,N/A,9,9,6,0.2,3,1.8,0.2,0.5,0,2.5,Established
,NPHS1,"congenital nephrotic syndrome, Finnish type",5535,1241,29,Yes,"Exon 1,2",324,266,82.1%,>3,Clustering is not observed,N/A,8,7,8,1,0,1.4,0.3,0.5,0.15,2.35,Established
,OAT,ornithine aminotransferase deficiency,2039,439,10,Yes,Exon 2-4,87,69,79.3%,>3,Clustering is not observed,N/A,5,5,4,0.3,0,1,0.3,0.5,0.15,1.95,Established
,ORC4,Meier-Gorlin syndrome 2,6547,436,14,Yes,Exon 10,17,14,82.4%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.3,0.15,1.05,Established
,OTOA,nonsyndromic genetic hearing loss,3878,1139,29,Yes,Exon 6,69,63,91.3%,>3,Clustering is not observed,N/A,5,5,4,0.3,2,1,0.3,0.5,0,1.8,Established
,PAX1,otofaciocervical syndrome 2,5342,457,5,Yes,Exon 1 ,11,10,90.9%,<3,Clustering observed,variants within two exons,6,6,6,0.3,2,1.2,0.3,0,0,1.5,Established
,PCCA,propionic acidemia,2484,728,24,Yes,"Exons 5,6,9,12,17,20,28,30",237,202,85.2%,>3,Clustering is not observed,N/A,7,7,7,1,0,1.4,0.3,0.5,0.15,2.35,Established
,PCYT1A,spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,5546,367,9,Yes,"Exons 5,14,15",9,5,55.6%,>3,Clustering is not observed,N/A,5,4,5,0,1,0.8,0,0.3,0.15,1.25,Established
,PDHX,Leigh syndrome,2500,504,11,Yes,"Exons 1,2,10,15",19,17,89.5%,>3,Clustering is not observed,N/A,5,5,4,0,1,1,0,0.3,0,1.3,Established
,PEX1,peroxisome biogenesis disorder,4369,1283,24,No,N/A,273,262,96.0%,>3,Clustering is not observed,N/A,7,5,7,0,0,1,0,0.5,0.15,1.65,Established
,PEX11B,peroxisome biogenesis disorder,1620,259,4,No,N/A,9,8,88.9%,3,Clustering is not observed,N/A,4,3,4,0.3,0,0.6,0.3,0.3,0.15,1.35,Established
,PEX14,peroxisome biogenesis disorder,1922,377,9,Yes,Exon 13,5,5,100.0%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.3,0.15,1.05,Established
,PEX16,peroxisome biogenesis disorder,1668,336,11,No,N/A,30,26,86.7%,>3,Clustering is not observed,N/A,5,4,5,0.2,0,0.8,0.2,0.5,0.15,1.65,Established
,PEX26,peroxisome biogenesis disorder,18626,305,5,Yes,Exon 6,47,41,87.2%,>3,Clustering is not observed,N/A,6,5,5,0,0,1,0,0.5,0.15,1.65,Established
,PEX3,peroxisome biogenesis disorder,2750,373,12,No,N/A,24,21,87.5%,>3,Clustering is not observed,N/A,5,5,5,0.2,0,1,0.2,0.5,0.15,1.85,Established
,PEX7,peroxisome biogenesis disorder,1454,323,10,Yes,"Exon 9,10,13",115,102,88.7%,>3,Clustering is not observed,N/A,7,5,6,0.3,0,1,0.3,0.5,0.15,1.95,Established
,PGAP3,hyperphosphatasia with intellectual disability syndrome 4,2687,320,8,Yes,Exon 1,23,16,69.6%,>3,Clustering is not observed,N/A,4,4,4,0,0,0.8,0,0.3,0.15,1.25,Established
,PGM1,PGM1-congenital disorder of glycosylation,2337,562,11,Yes,"Exons 3,4",25,19,76.0%,>3,Clustering is not observed,N/A,4,4,4,0.3,1,0.8,0.3,0.3,0,1.4,Established
,PHKB,glycogen storage disease IXb,5459,1093,31,Yes,Exon 34,80,78,97.5%,>3,Clustering is not observed,N/A,6,4,4,0.3,2,0.8,0.3,0.5,0,1.6,Established
,PHYH,phytanoyl-CoA hydroxylase deficiency,1541,338,9,Yes,Exon 3,58,52,89.7%,>3,Clustering is not observed,N/A,7,5,7,0.3,1,1,0.3,0.5,0,1.8,Established
,PIGN,multiple congenital anomalies-hypotonia-seizures syndrome 1,7936,931,31,Yes,"Exons 3-5, 19, 20, 27, 28",144,126,87.5%,>3,Clustering is not observed,N/A,3,3,3,0,1,0.6,0,0.5,0,1.1,Established
,PIGO,Complex neurodevelopmental disorder,4112,1089,11,No,N/A,68,63,92.6%,>3,Clustering is not observed,N/A,6,5,6,0,0,1,0,0.5,0.15,1.65,Established
,PINK1,Parkinson disease,2657,581,8,Yes,Exon 6,14,13,92.9%,3,Clustering is not observed,N/A,6,6,5,0.3,2,1.2,0.3,0.3,0,1.8,Established
,PLA2G6,PLA2G6-associated neurodegeneration,3299,806,17,Yes,"Exon 1,2,4,6",141,80,56.7%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,PLCB1,developmental and epileptic encephalopathy,7088,1216,32,Yes,"Exon 1,2,4,6-11, 28, 34,35,44,45,47",21,20,95.2%,>3,Clustering is not observed,N/A,5,5,4,0.3,3,1,0.3,0.5,0,1.8,Established
,PLEKHG5,neuromuscular disease,3580,1006,21,Yes,Exon 1,62,61,98.4%,>3,Clustering is not observed,N/A,2,2,2,0.3,4,0.4,0.3,0.5,0,1.2,Established
,POLH,xeroderma pigmentosum variant type,8368,713,11,No,N/A,36,35,97.2%,>3,Clustering is not observed,N/A,10,10,9,0.3,0,2,0.3,0.5,0.15,2.95,Established
,POMT2,myopathy caused by variation in POMT2,4875,750,21,Yes,"Exons 2-4,13,17",115,104,90.4%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,POR,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,2446,677,16,Yes,"Exons 1-8,10,11",64,56,87.5%,>3,Clustering is not observed,N/A,5,3,5,0.3,0,0.6,0.3,0.5,0.15,1.55,Established
,PPT1,neuronal ceroid lipofuscinosis,2284,306,9,Yes,"Exons 2,3,10",132,95,72.0%,>3,Clustering is not observed,N/A,5,3,4,0.3,0,0.6,0.3,0.5,0.15,1.55,Established
,PRG4,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,5049,1404,13,Yes,Exon 1,21,21,100.0%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,PTS,BH4-deficient hyperphenylalaninemia A,872,145,6,Yes,"Exon 8,10",66,37,56.1%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,PXDN,anterior segment dysgenesis 7,6817,1479,23,Yes,"Exon 1,4,20,23",16,14,87.5%,>3,Clustering is not observed,N/A,7,6,7,0.3,1,1.2,0.3,0.3,0,1.8,Established
,PYCR1,autosomal recessive cutis laxa type 2B,2269,319,7,Yes,"Exons 1,2,12",29,17,58.6%,>3,Clustering is not observed,N/A,5,5,5,0.2,2,1,0.2,0.3,0,1.5,Established
,QDPR,dihydropteridine reductase deficiency,1507,244,7,Yes,"Exon 2,9",32,19,59.4%,>3,Clustering is not observed,N/A,5,5,5,0.1,0,1,0.1,0.3,0.15,1.55,Established
,RAB28,RAB28-related retinopathy,1690,221,7,Yes,Exon 5,13,11,84.6%,>3,Clustering is not observed,N/A,5,4,5,0.3,0,0.8,0.3,0.3,0.15,1.55,Established
,RAB3GAP2,Warburg micro syndrome,7256,1393,35,Yes,"Exon 2,5,8",33,29,87.9%,>3,Clustering is not observed,N/A,13,12,13,0,1,2.4,0,0.5,0,2.9,Established
,RAG1,recombinase activating gene 1 deficiency,6588,1043,2,Yes,"Exons 2,4,6-9,12",141,86,61.0%,<3,"Cannot determine, only 1 exon",All variants in 1 exon,9,9,9,0.3,0,1.8,0.3,0,0.15,2.25,Established
,RAG2,recombinase activating gene 2 deficiency,2388,527,2,No,N/A,116,58,50.0%,<3,Clustering is not observed,N/A,7,7,7,0.3,0,1.4,0.3,0.3,0.15,2.15,Established
,RARS2,mitochondrial disease,2242,578,20,Yes,"Exon 3,20",202,177,87.6%,>3,Clustering is not observed,N/A,3,3,3,0,0,0.6,0,0.5,0.15,1.25,Established
,RDX,nonsyndromic genetic hearing loss,4392,583,14,Yes,"Exons 2,4,13,20,21",21,20,95.2%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,RIN2,RIN2 syndrome,4440,895,13,Yes,Exon 3 ,12,12,100.0%,>3,Clustering is not observed,N/A,4,4,4,0,0,0.8,0,0.3,0.15,1.25,Established
,RMND1,mitochondrial disease,1948,449,12,Yes,Exon 3,33,24,72.7%,>3,Clustering is not observed,N/A,5,5,5,0,0,1,0,0.5,0.15,1.65,Established
,RNF168,RIDDLE syndrome,5347,571,6,No,N/A,19,19,100.0%,>3,Clustering is not observed,N/A,3,3,3,0.3,2,0.6,0.3,0.3,0,1.2,Established
,ROBO3,"gaze palsy, familial horizontal, with progressive scoliosis 1",4528,1386,28,Yes,Exon 1-3,24,9,37.5%,>3,Clustering is not observed,N/A,7,7,6,0.3,3,1.4,0.3,0.3,0,2,Established
,ROGDI,amelocerebrohypohidrotic syndrome,1418,287,11,No,N/A,37,34,91.9%,>3,Clustering is not observed,N/A,6,6,6,0,1,1.2,0,0.5,0,1.7,Established
,RPE65,RPE65-related recessive retinopathy,2605,533,14,No,N/A,237,143,60.3%,>3,Clustering is not observed,N/A,7,6,7,0.3,0,1.2,0.3,0.5,0.15,2.15,Established
,RSPH4A,primary ciliary dyskinesia 11,2840,716,6,No,N/A,40,37,92.5%,>3,Clustering is not observed,N/A,18,10,15,0,3,2,0,0.5,0,2.5,Established
,SBDS,Shwachman-Diamond syndrome,1613,250,5,No,N/A,41,31,75.6%,>3,Clustering is not observed,N/A,16,5,8,0.3,1,1,0.3,0.5,0,1.8,Established
,SBF2,Charcot-Marie-Tooth disease type 4B2,7450,1849,40,Yes,"Exons 1,3,31,34",32,30,93.8%,>3,Clustering is not observed,N/A,7,7,6,0.3,1,1.4,0.3,0.5,0,2.2,Established
,SERAC1,Leigh syndrome,3936,654,17,Yes,"Exons 2,9",46,36,78.3%,>3,Clustering is not observed,N/A,5,5,5,0,0,1,0,0.5,0.15,1.65,Established
,SERPINB6,nonsyndromic genetic hearing loss,1315,376,7,No,N/A,2,1,50.0%,<3,"Cannot determine, only 1 exon","Only one variant, one exon",3,3,2,0.3,0,0.6,0.3,0,0.15,1.05,Established
,SGCG,autosomal recessive limb-girdle muscular dystrophy,1594,291,8,No,N/A,92,85,92.4%,>3,Clustering is not observed,N/A,7,6,6,0,0,1.2,0,0.5,0.15,1.85,Established
,SGSH,mucopolysaccharidosis type 3A,2705,502,8,Yes,Exon 1,162,110,67.9%,>3,Clustering is not observed,N/A,5,5,5,0,0,1,0,0.5,0.15,1.65,Established
,SH3TC2,obsolete autosomal recessive hereditary demyelinating motor and sensory neuropathy,26468,1288,17,Yes,"Exon 4,22",135,115,85.2%,>3,Clustering is not observed,N/A,8,5,7,0.3,1,1,0.3,0.5,0,1.8,Established
,SIL1,Marinesco-Sjogren syndrome,1889,461,10,Yes,"Exons 4,7,9-11,15,16,21",25,24,96.0%,>3,Clustering is not observed,N/A,6,5,6,0.3,0,1,0.3,0.5,0.15,1.95,Established
,SLC17A5,free sialic acid storage disease,3292,495,11,No,N/A,110,95,86.4%,>3,Clustering is not observed,N/A,7,7,5,0.3,0,1.4,0.3,0.5,0.15,2.35,Established
,SLC25A1,mitochondrial disease,1548,311,9,No,N/A,20,12,60.0%,>3,Clustering is not observed,N/A,4,3,3,0,0,0.6,0,0.3,0.15,1.05,Established
,SLC25A13,citrin deficiency,3141,675,18,Yes,"Exons 2,17",166,144,86.7%,>3,Clustering is not observed,N/A,12,7,8,0.1,0,1.4,0.1,0.5,0.15,2.15,Established
,SLC34A1,"hypercalcemia, infantile, 2",2583,639,13,Yes,Exon 1,29,24,82.8%,>3,Clustering is not observed,N/A,5,5,5,0.3,1,1,0.3,0.5,0,1.8,Established
,SLC38A8,foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome,1672,435,11,Yes,Exon 1,56,53,94.6%,>3,Clustering is not observed,N/A,9,7,8,0,0,1.4,0,0.5,0.15,2.05,Established
,SLC3A1,cystinuria,2969,685,10,Yes,Exon 10,49,29,59.2%,>3,Clustering is not observed,N/A,6,6,6,0.3,2,1.2,0.3,0.5,0,2,Established
,SLC52A3,Brown-Vialetto-van Laere syndrome 1,2611,469,5,No,N/A,22,15,68.2%,>3,Clustering is not observed,N/A,4,3,4,0.3,1,0.6,0.3,0.3,0,1.2,Established
,SLC7A7,lysinuric protein intolerance,2082,511,10,Yes,"Exons 9,10,12",107,99,92.5%,>3,Clustering is not observed,N/A,7,6,7,0.3,0,1.2,0.3,0.5,0.15,2.15,Established
,SLC7A9,cystinuria,1766,487,13,No,N/A,47,30,63.8%,>3,Clustering is not observed,N/A,2,2,2,0.3,1,0.4,0.3,0.5,0,1.2,Established
,SPEG,"myopathy, centronuclear, 5",10782,3267,41,Yes,"Exons 2,3,15, 53",11,11,100.0%,>3,Clustering is not observed,N/A,10,10,7,0.3,0,2,0.3,0.3,0.15,2.75,Established
,STIL,autosomal recessive primary microcephaly,5019,1288,17,No,N/A,16,13,81.3%,>3,Clustering is not observed,N/A,2,2,2,0.2,0,0.4,0.2,0.3,0.15,1.05,Established
,STRC,nonsyndromic genetic hearing loss,5515,1775,29,Yes,"Exons 2-6,10",54,42,77.8%,>3,Clustering is not observed,N/A,5,5,5,0.3,8,1,0.3,0.5,0,1.8,Established
,STX11,familial hemophagocytic lymphohistiocytosis 4,5504,287,2,No,N/A,27,25,92.6%,<3,"Cannot determine, only 1 exon",N/A,8,7,7,0.3,0,1.4,0.3,0,0.15,1.85,Established
,SUMF1,mucosulfatidosis,2147,374,9,Yes,"Exon 17,20",84,61,72.6%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
,SYNE4,nonsyndromic genetic hearing loss,1377,404,8,No,N/A,34,32,94.1%,>3,Clustering is not observed,N/A,3,2,3,0.3,1,0.4,0.3,0.5,0,1.2,Established
,TCIRG1,autosomal recessive osteopetrosis 1,2668,830,20,Yes,Exon 11,229,213,93.0%,>3,Clustering is not observed,N/A,14,12,8,0.3,0,2.4,0.3,0.5,0.15,3.35,Established
,TCTN2,Joubert syndrome 24,2908,697,18,Yes,Exon 19,54,50,92.6%,>3,Clustering is not observed,N/A,7,7,6,0.3,1,1.4,0.3,0.5,0,2.2,Established
,TECTA,nonsyndromic genetic hearing loss,7353,2155,24,Yes,"Exon 1,12",68,53,77.9%,>3,Clustering is not observed,N/A,6,6,6,0.3,1,1.2,0.3,0.5,0,2,Established
,TMEM231,ciliopathy,4247,316,7,No,N/A,29,17,58.6%,>3,Clustering is not observed,N/A,2,2,2,0.3,0,0.4,0.3,0.3,0.15,1.15,Established
,TMEM237,Joubert syndrome 14,5399,408,13,Yes,Exon 8,35,34,97.1%,>3,Clustering is not observed,N/A,14,9,10,0,0,1.8,0,0.5,0.15,2.45,Established
,TMPRSS3,nonsyndromic genetic hearing loss,2396,453,13,Yes,Exon 8,83,43,51.8%,>3,Clustering is not observed,N/A,4,3,4,0.3,2,0.6,0.3,0.5,0,1.4,Established
,TNNT1,nemaline myopathy 5,1111,278,14,Yes,Exon 16,24,22,91.7%,>3,Clustering is not observed,N/A,6,6,6,0.3,0,1.2,0.3,0.5,0.15,2.15,Established
,TPRN,nonsyndromic genetic hearing loss,2659,722,4,No,N/A,11,11,100.0%,<3,Clustering is not observed,N/A,6,5,6,0.3,3,1,0.3,0,0,1.3,Established
,TRAPPC9,intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,6899,1148,23,Yes,"Exons 1,12,20,22,23,28,30",62,54,87.1%,>3,Clustering is not observed,N/A,8,5,7,0,0,1,0,0.5,0.15,1.65,Established
,TRDN,long QT syndrome,4627,729,41,No,N/A,41,36,87.8%,>3,Clustering is not observed,"While variants are across multiple exons, it seems to be one end of the transcript",7,3,6,0,4,0.6,0,0.5,0,1.1,Established
,TRMU,Leigh syndrome,1651,421,11,Yes,Exon 5,134,121,90.3%,>3,Clustering is not observed,N/A,2,2,2,0.1,0,0.4,0.1,0.5,0.15,1.15,Established
,TTC19,Leigh syndrome,3050,380,10,Yes,"Exon 1,13",16,16,100.0%,>3,Clustering is not observed,N/A,7,7,7,0.3,1,1.4,0.3,0.3,0,2,Established
,TTC7A,multiple intestinal atresia,5095,858,20,Yes,"Exon 9,21",52,48,92.3%,>3,Clustering is not observed,N/A,3,3,2,0,1,0.6,0,0.5,0,1.1,Established
,TTLL5,TTLL5-related retinopathy,4716,1281,32,Yes,"Exons 1,3,7,12,16,21",83,81,97.6%,>3,Clustering is not observed,N/A,5,5,4,0.3,3,1,0.3,0.5,0,1.8,Established
,TUBGCP6,microcephaly and chorioretinopathy 1,666,1819,25,No,N/A,99,97,98.0%,>3,Clustering is not observed,N/A,7,7,6,0,4,1.4,0.3,0.5,0,2.2,Established
,TUSC3,intellectual disability,3697,348,11,Yes,"Exon 1,2,4,11",12,10,83.3%,>3,Clustering is not observed,N/A,5,5,5,0,0,1,0,0.3,0.15,1.45,Established
,TYMP,mitochondrial disease,1586,482,10,Yes,"Exon 8,9",69,51,73.9%,>3,Clustering is not observed,N/A,4,4,4,0.2,1,0.8,0.2,0.5,0,1.5,Established
,UBE3B,"oculocerebrofacial syndrome, Kaufman type",5730,1068,28,No,N/A,46,43,93.5%,>3,Clustering is not observed,N/A,8,8,8,0.3,0,1.6,0.3,0.5,0.15,2.55,Established
,VLDLR,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",9213,873,19,No,N/A,44,43,97.7%,>3,Clustering is not observed,N/A,9,8,8,0.2,1,1.6,0.2,0.5,0,2.3,Established
,VPS13B,Cohen syndrome,14011,3997,62,Yes,"Exons 18,19,23,25,26",753,730,96.9%,>3,Clustering is not observed,N/A,10,9,8,0,2,1.8,0,0.5,0,2.3,Established
,WDR35,short-rib thoracic dysplasia 7 with or without polydactyly,6898,1170,27,No,N/A,42,35,83.3%,>3,Clustering is not observed,N/A,8,4,8,0,0,0.8,0,0.5,0.15,1.45,Established
,WDR72,amelogenesis imperfecta,7310,1102,20,Yes,"Exons 1,3,4,17,23",15,13,86.7%,>3,Clustering is not observed,N/A,7,5,6,0.3,0,1.4,0.3,0.3,0.15,2.15,Established
,WHRN,Usher syndrome type 2D,4070,907,12,Yes,Exon 3,35,35,100.0%,>3,Clustering is not observed,N/A,3,3,3,0,1,0.6,0,0.5,0,1.1,Established
,WWOX,developmental and epileptic encephalopathy,2241,414,9,Yes,"Exons 7,8,10-15,17,21-24",61,49,80.3%,>3,Clustering is not observed,N/A,5,3,5,0.3,9,0.6,0.3,0.5,0,1.4,Established
,XPA,xeroderma pigmentosum group A,1400,273,6,No,N/A,96,89,92.7%,>3,Clustering is not observed,N/A,6,6,6,0.3,0,1.2,0.3,0.5,0.15,2.15,Established
,XPC,xeroderma pigmentosum group C,3650,940,16,Yes,Exon 10,174,171,98.3%,>3,Clustering is not observed,N/A,5,5,5,0.3,0,1,0.3,0.5,0.15,1.95,Established
